Physician-nurse Team to Reduce Emergency Department (ED) Overcrowding

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Olivier T. Rutschmann, University Hospital, Geneva
ClinicalTrials.gov Identifier:
NCT01219868
First received: October 6, 2010
Last updated: March 19, 2013
Last verified: March 2013
  Purpose

The objective of this study is to explore the impact of a physician-nurse team supervising patient's flow on ED length of stay


Condition Intervention
Triage
Behavioral: Physician-nurse team supervision

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Impact of Physician-nurse Team on ED Length of Stay

Further study details as provided by University Hospital, Geneva:

Primary Outcome Measures:
  • ED length of stay [ Time Frame: 3 months ] [ Designated as safety issue: No ]

Enrollment: 8000
Study Start Date: October 2010
Study Completion Date: March 2011
Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Physician-nurse team Behavioral: Physician-nurse team supervision
Physician-nurse team will supervise patient's flow in the ED
Other Name: No name

Detailed Description:

A physician-nurse team will be in charge of patients flow in the ED during intervention periods. During control periods, no team will be present. The impact of this team on Ed length of stay will be assessed.

  Eligibility

Ages Eligible for Study:   16 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • all adult patients > 16 years presenting to the ED

Exclusion Criteria:

  • no
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01219868

Locations
Switzerland
ED of Geneva University Hospitals
Geneva, Switzerland, 1211
Sponsors and Collaborators
University Hospital, Geneva
Investigators
Principal Investigator: Olivier T Rutschmann, MD, MPH HUG
  More Information

No publications provided

Responsible Party: Olivier T. Rutschmann, MD, MPH, University Hospital, Geneva
ClinicalTrials.gov Identifier: NCT01219868     History of Changes
Other Study ID Numbers: SU-001
Study First Received: October 6, 2010
Last Updated: March 19, 2013
Health Authority: Switzerland: Ethikkommission

ClinicalTrials.gov processed this record on October 01, 2014